Evonik Industries AG

Steag, through its subsidiaries, is engaged mainly in power generation and related industries. Co.'s business is divided into five units: Power generation, Decentralized Energy Supply, Foreign Power Plants, Gas Distribution, and Coal Trading.
  • TickerEVNK01
  • ISINDE000EVNK013
  • SectorChemicals
  • CountryGermany

Analysts

An increasingly favourable environment allows EVONIK INDUSTRIES AG to improve to Neutral

The independent financial analyst theScreener just upgraded the general evaluation of EVONIK INDUSTRIES AG (DE), a company active in the Specialty Chemicals industry. As regards its fundamental valuation, the title confirms its rating of 3 out of 4 stars while its market behaviour remains as risky. theScreener believes, however, that a more enabling environment allows the title to increase its general evaluation to Neutral. As of the analysis date September 13, 2019, the closing price was EUR 24.28 and its expected value was estimated at EUR 23.52.

1 director bought

A director at Evonik Industries AG bought 7,630 shares at 26.239EUR and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names o...

Expert Corporate Governance Service (ECGS)

Evonik Industries - AGM 28 May 2019

Item 5: PwC, Frankfurt am Main, is proposed as auditor for the current financial year. We have no concerns over the ratio of non-audit/audit fees. However, we note that PwC has audited the Company since the financial year 2007 which exceeds our maximum acceptable term of office. We therefore recommend opposing the re-election of PwC as auditor.

Evonik Industries AG - December 2017 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Evonik Industries AG - September 2017 (LTM): Peer Snapshot

Peer Snapshot:  Evonik Industries AG - September 2017 (LTM) 4 January 2018 (in US millions) FYE Dec-15 FYE Dec-16 LTM Sep-17 FYE Dec-15 FYE Dec-16 LTM Sep-17 FYE Dec-15 FYE Dec-16 LTM

Evonik Industries AG - June 2017 (LTM): Peer Snapshot

Peer Snapshot:  Evonik Industries AG - June 2017 (LTM) 4 October 2017 (in US millions) FYE Dec-15 FYE Dec-16 LTM Jun-17 FYE Dec-15 FYE Dec-16 LTM Jun-17 FYE Dec-15 FYE Dec-16 LTM Jun-17

Moody's assigns (P)Baa3 rating to Evonik's new hybrid notes; stable outlook

Rating Action: Moody's assigns Baa3 rating to Evonik's new hybrid notes; stable outlook. Global Credit Research- 28 Jun 2017. London, 28 June 2017-- Moody's Investors Service, has today assigned a provisional Baa3 rating to the proposed issuance of Subordinated Resettable Fixed Rate Notes by Evonik Industries AG.

Evonik Industries AG - March 2017 (LTM): Peer Snapshot

Peer Snapshot:  Evonik Industries AG - March 2017 (LTM) 7 June 2017 (in US millions) FYE Dec-15 FYE Dec-16 LTM Mar-17 FYE Dec-14 FYE Dec-15 LTM Dec-16 FYE Dec-14 FYE Dec-15 LTM Dec-16

Rob Hales

Morningstar | Evonik Reports In-Line 1Q; Shares Fairly Valued

No-moat Evonik Industries reported first-quarter results that were in line with consensus. EBITDA of EUR 539 million was down 3% over 2018 due primarily to weaker results in nutrition and care. The more industrial-focused resource efficiency segment reported modest growth in EBITDA despite the challenging macro environment. Evonik upgraded its 2019 guidance, but this mainly reflects adjustments after the sale of the methacrylates business, which is now excluded from continuing operations. Evonik now expects 2019 EBITDA to be at least stable, compared with previous guidance of slightly lower or...

Rob Hales

Evonik Reports In-Line 1Q; Shares Fairly Valued

No-moat Evonik Industries reported first-quarter results that were in line with consensus. EBITDA of EUR 539 million was down 3% over 2018 due primarily to weaker results in nutrition and care. The more industrial-focused resource efficiency segment reported modest growth in EBITDA despite the challenging macro environment. Evonik upgraded its 2019 guidance, but this mainly reflects adjustments after the sale of the methacrylates business, which is now excluded from continuing operations. Evonik...

Rob Hales

Morningstar | EVK Updated Forecasts and Estimates from 16 Apr 2019

No-moat Evonik shares traded up 5% intraday after the company announced a better-than-expected sale price for its methacrylates business and a sustainable annual cash flow increase of EUR 100 million from pension reimbursements. The pension reimbursement was a surprise and provides much-needed security for dividend coverage with loss of the methacrylates cash flow contribution. Fourth-quarter results were in line with expectations, but guidance for 2019 is slightly lower than our forecast. We are likely to trim our near-term forecast, but this is offset by the methacrylates sale. Consequently,...

Rob Hales

Morningstar | Evonik Gets Good Price on Methacrylates Sale; Dividend Shored Up

No-moat Evonik shares traded up 5% intraday after the company announced a better-than-expected sale price for its methacrylates business and a sustainable annual cash flow increase of EUR 100 million from pension reimbursements. The pension reimbursement was a surprise and provides much-needed security for dividend coverage with loss of the methacrylates cash flow contribution. Fourth-quarter results were in line with expectations, but guidance for 2019 is slightly lower than our forecast. We are likely to trim our near-term forecast, but this is offset by the methacrylates sale. Consequently,...

Rob Hales

Evonik Gets Good Price on Methacrylates Sale; Dividend Shored Up

No-moat Evonik shares traded up 5% intraday after the company announced a better-than-expected sale price for its methacrylates business and a sustainable annual cash flow increase of EUR 100 million from pension reimbursements. The pension reimbursement was a surprise and provides much-needed security for dividend coverage with loss of the methacrylates cash flow contribution. Fourth-quarter results were in line with expectations, but guidance for 2019 is slightly lower than our forecast. We ar...

1 director bought

A director at Evonik Industries AG bought 7,630 shares at 26.239EUR and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names o...

An increasingly favourable environment allows EVONIK INDUSTRIES AG to improve to Neutral

The independent financial analyst theScreener just upgraded the general evaluation of EVONIK INDUSTRIES AG (DE), a company active in the Specialty Chemicals industry. As regards its fundamental valuation, the title confirms its rating of 3 out of 4 stars while its market behaviour remains as risky. theScreener believes, however, that a more enabling environment allows the title to increase its general evaluation to Neutral. As of the analysis date September 13, 2019, the closing price was EUR 24.28 and its expected value was estimated at EUR 23.52.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

Expert Corporate Governance Service (ECGS)

Evonik Industries - AGM 28 May 2019

Item 5: PwC, Frankfurt am Main, is proposed as auditor for the current financial year. We have no concerns over the ratio of non-audit/audit fees. However, we note that PwC has audited the Company since the financial year 2007 which exceeds our maximum acceptable term of office. We therefore recommend opposing the re-election of PwC as auditor.

Evonik Industries – Proxinvest Corporate Governance Rating ® : C

Proxinvest Corporate Governance Rating ® helps investors integrate governance into their investment decision and identify governance risks and opportunities within their portfolio. Proxinvest Corporate Governance Rating ® Service rates European issuers through the analysis of four main themes : Ownership & Shareholder rights, Board & Committees, Audit & Process, Remuneration. Each theme is rated taking into account several comprehensive sub-categories. Our unique two-step process to achieve each rating includes a first step quantitative valuation and a second step qualitative filter...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch